Leiner OTC Sales Up 51% In FY 2000 With $33 Mil. From Granutec & Stanley
This article was originally published in The Tan Sheet
Executive Summary
Leiner Health Products' private label OTC drug sales rose 51% to $98.8 mil. in fiscal 2000, boosted by a $33 mil. net sales contribution from the Granutec and Stanley businesses.